![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 23, 20139-20145, June 7, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Section of Fluorescence Studies, Laboratory of Membrane
Biochemistry and Biophysics, National Institute on Alcohol Abuse
and Alcoholism, National Institutes of Health,
Rockville, Maryland 20852
Received for publication, January 18, 2002, and in revised form, February 22, 2002
The effect of cholesterol on rod outer segment
disk membrane structure and rhodopsin activation was investigated.
Disk membranes with varying cholesterol concentrations were
prepared using methyl- Cholesterol modulates the function of a variety of
membrane proteins including receptors and channels (1-6); this effect can be either inhibitory (1, 3) or stimulatory (2, 5). Currently, two
mechanisms are generally discussed regarding the effect of cholesterol
on membrane protein function. These are either a specific
cholesterol-membrane protein interaction (3-5) or a
cholesterol-induced alteration of lipid acyl chain interactions inducing domain or "raft" formation or otherwise affecting bilayer physical properties (3, 4, 7, 8). Discrimination between these two
mechanisms requires concomitant characterization of the influence of
cholesterol on membrane bilayer structural properties and protein function.
In this study, the visual system, a prototypical G protein-coupled
receptor system, is studied to determine the effect of varied
cholesterol content in the native
ROS1 disk membrane on
receptor activation. In visual transduction, rhodopsin serves as the
receptor, and light activates rhodopsin by converting its covalently
bound antagonist, 11-cis retinal, to its agonist,
all-trans retinal (9). Within milliseconds of light
absorption, MII, the photointermediate that binds and activates the
visual G protein transducin, is formed and exists in a metastable
equilibrium with its inactive precursor, MI. Previous studies in
reconstituted systems clearly demonstrate that the formation of MII is
strongly dependent on the physical properties of bilayer lipids (7, 8,
10).
One unique feature of ROS disk membranes is that the cholesterol
concentration exists as a gradient running along the long axis of the
rod cell (11). The basal disks, which are newly formed, contain 30 mol
% cholesterol, whereas the apical disks contain only 5 mol % cholesterol (11). The physiological role of the cholesterol
gradient is unclear, although it may be important to visual signal
transduction because higher cholesterol is linked to reduced
phosphodiesterase activity downstream in the visual cascade (12). The
disk membrane is also unusual in that approximately 50% of the
phospholipid acyl chains are derived from docosahexanoic acid
(DHA), making the disk one of the most polyunsaturated membranes in the
human body (13, 14). The major lipid classes in the disk membrane are
phosphatidylcholine (PC), phosphatidylenthanolamine, and
phosphatidylserine at 40, 41, and 12.5 mol %, respectively (13, 14).
The disk also contains low levels of phosphatidylinositol, phosphatidic
acid, and diacylglycerol and insignificant amounts of sphingomyelin.
The major protein in disk membranes is rhodopsin, which accounts for
>90% of the total membrane protein (15, 16). Rhodopsin is the best
characterized G protein-coupled receptor in terms of structure and
function (17, 18), which makes the disk membrane an ideal system for
investigating the mechanism whereby cholesterol modulates receptor function.
In this study, disk membranes varying in cholesterol concentration were
prepared using methyl- Sample Preparation--
Cholesterol and MBCD were purchased from
Sigma. Cholesterol-MBCD complex was prepared by premixing
cholesterol and MBCD as solids (weight ratio of 1:20) followed by
solubilization in degassed TBS buffer consisting of 10 mM
Tris, 60 mM NaCl, 30 mM KCl, 50 µM diethylenetriamine pentaacetic acid, pH 7.5. The
solution was sealed in argon and shaken at room temperature overnight.
The final solution was filtered through a 0.45-µm filter and assayed for final cholesterol concentration (21). Cholesterol CII assay kit was
from WAKO (Richmond, VA). BCA protein assay kit and Coomassie Plus
protein assay kit were from Pierce. ROS were isolated from frozen
bovine retinas (James and Wanda Lawson, Lincoln, NE) as described by
Miller et al. (22). Intact disk membranes were prepared
using the Ficoll floatation method (15). Unless otherwise stated, all
disk manipulations and measurements were conducted under argon in the
dark with the aid of night vision goggles.
Membrane Cholesterol Manipulation Using
MBCD--
Cholesterol-depleted disk membranes were prepared by
incubating disk membranes with various concentrations of MBCD (0-40
mM) in TBS buffer, pH 7.5. Samples were incubated at room
temperature in the dark for 2 h on a shaker. Measurements of disk
cholesterol content at several time points indicated that 2 h was
a sufficient incubation time to reach equilibrium for cholesterol
exchange between disk membranes and MBCD (data not shown). The
MBCD-treated disk membranes were then separated from MBCD by
centrifugation followed by two additional washes in TBS buffer. The
membrane pellet and MBCD-containing supernatant were assayed for
cholesterol (21), phospholipids (23), and rhodopsin (24, 25), and the
mole percentage of cholesterol to total phospholipids in disk membranes
was determined. Cholesterol-enriched disk membranes were prepared
similarly, except that disk membranes were incubated with
cholesterol-loaded MBCD (0-1.2 mM cholesterol in 10 mM MBCD). The mole percentage of cholesterol in
samples prepared in this study were used as follows: 4, 12, 15, and 38 mol %, where the 15 mol % cholesterol sample was the native disk
membrane without MBCD treatment.
MI-MII Equilibrium Measurements--
Disk membranes were
extruded through 0.2-µm membranes using a LiposoFast extruder
(Avestin, Ottawa, Canada) to reduce light scattering. The final sample
was suspended at 0.3 mg/ml in pH 7.5 TBS buffer for UV-visible
absorption measurements. Briefly, 110-µl samples were equilibrated in
a quartz cuvette for 5 min at 37 °C in the dark. Four spectra of
each sample were recorded at the following time points: 1) after
temperature equilibration in the dark; 2) 3 s after the sample was
partially bleached (20-30%) by a flash lamp equipped with a 520-nm
broad bandpass filter; 3) after incubation with 30 mM
hydroxylamine for 10 min; 4) after the sample was fully bleached. The
first absorption spectrum is of dark-adapted rhodopsin. Within
milliseconds, photoexcited rhodopsin exists in a metastable
equilibrium between MI and MII. The equilibrium spectra of MI and MII
and associated Keq were determined by taking appropriate difference spectra as previously described (26).
Fluorescence Measurements--
Samples for fluorescence
measurements were made immediately prior to use by diluting a
concentrated disk solution to 100 µM phospholipid and
adding 0.3 µl of DPH in tetrahydrofuran to yield a final
phospholipid/DPH ratio of 300:1. Argon was streamed into the cuvette
during this entire process, and the added tetrahydrofuran was allowed
to evaporate by continuing the argon stream for several minutes
following addition of DPH. All samples were incubated at 40 °C in
darkness for 1 h before being brought to 37 °C for measurement.
Total optical density (scatter plus absorption) at the wavelength of
fluorescence excitation was less than 0.1. Fluorescence lifetime and
differential polarization measurements were performed with a K2
multifrequency cross-correlation phase fluorimeter (ISS, Urbana, IL).
Excitation at 351 nm was provided by an Innova 307 argon ion laser
(Coherent Radiation, Palo Alto, CA). Lifetime and differential
polarization data were acquired at 15 modulation frequencies,
logarithmically spaced from 5 to 200 MHz using decay acquisition
software from ISS as previously described (20). Both total intensity
decay and differential polarization measurements were repeated with
each cholesterol composition a minimum of three times.
Total fluorescence intensity decays were modeled as the sum of two
discrete exponential decays. To compare the effects of cholesterol
content on the average fluorescence lifetime, the intensity-weighted
average fluorescence lifetime <
where ro is the fluorescence anisotropy
at t = 0, r
The empirical sum of exponentials model provides information about
fluorophore rotational correlation times and the extent to which the
fluorescence anisotropy can decay to zero. However, it provides no
information regarding the range of equilibrium angular orientations to
which DPH is restricted by the surrounding matrix of phospholipid acyl
chains. Therefore all data were also analyzed using the Brownian
rotational diffusion model as previously described (20). It is
useful to calculate a single parameter that corresponds to the extent
to which the equilibrium orientational freedom of DPH is restricted by
the phospholipid acyl chains. Such a parameter is DSC Measurements--
DSC measurements were performed in a
Nano-scan II calorimeter (Calorimetry Sciences, Provo, UT). Disk
membranes at a concentration of 1.0 mg/ml rhodopsin in pH 7.0 PIPES
basic salt (PIBS) buffer containing 10 mM PIPES, 60 mM KCl, 30 mM NaCl, and 50 µM
diethylenetriamine pentaacetic acid were degassed and loaded into
sample cells in complete darkness. The cell was sealed under a stream
of argon and pressurized to 2.8 atm. After temperature equilibration
was reached, samples were scanned at 0.5 °C/min, and the data were analyzed using Cp-Cal 2.1 provided by Calorimetry Sciences.
Manipulation of the Disk Membrane Cholesterol Content by
MBCD--
The native ROS disk membrane preparation contained 15 mol % cholesterol. Incubation of disk membranes with increasing amounts of
MBCD resulted in a successive depletion of cholesterol from disk
membranes (Fig. 1A). In the
presence of 10 mM MBCD mixed with 1 mM disk
membrane phospholipids, 65% of cholesterol was removed from disk
membranes. Higher concentration of MBCD resulted in a further depletion
of cholesterol from disk membranes. Control experiments were conducted
to evaluate the potential risks for co-removal of phospholipids and
rhodopsin from disk membranes by MBCD. No rhodopsin was extracted from
disk membranes in the presence of MBCD up to 40 mM,
indicating that MBCD has no affinity for rhodopsin relative to disk
membranes. However, a small fraction of phospholipids was
extracted from disk membranes at lower MBCD concentrations (Table
I). The amount of phospholipids extracted became significant at concentrations of MBCD above 15 mM.
We used 10 mM MBCD in all cholesterol depletion
preparations to maximize the removal of cholesterol while minimizing
the extraction of phospholipids.
Analysis of the data in Fig. 1A (according to a simple
equilibrium partitioning model) resulted in a partition coefficient of
5.2 ± 0.8, indicating that under conditions of equal amounts of
disk membrane and MBCD, cholesterol partitions 5.2-fold higher into
disk membranes than into MBCD. The equilibrium partition model was
tested by enriching the amount of cholesterol in disk membranes by
incubating them with 10 mM MBCD preloaded with various amounts of cholesterol. The agreement between observed levels of
cholesterol enrichment and the levels calculated from the equilibrium partition model as shown in Fig. 1B confirm that an
equilibrium-partition model is followed for cholesterol exchange
between MBCD and disk membranes. Using the combination of MBCD and
cholesterol-MBCD complex, we were able to manipulate the cholesterol
concentration in disk membranes in a wide range.
Cholesterol Inhibits Rhodopsin Activation--
The effect of
membrane cholesterol on rhodopsin activation was investigated in disk
membranes by varying the membrane cholesterol concentration. Overall,
an inverse correlation between membrane cholesterol content and
Keq for the MI-MII equilibrium was observed at
37 °C, as shown in Fig. 2. In control
disk membranes the cholesterol concentration was 15 mol %, and
Keq was 0.81 ± 0.08. In
cholesterol-depleted disk membranes, which have a cholesterol level of
4 mol %, similar to the 5 mol % found in disks in the apical portion
of the ROS, Keq was 1.00 ± 0.10. In disk
membranes containing 31 mol % cholesterol, which correspond to
cholesterol levels of the basal disks in the ROS,
Keq was reduced to 0.73 ± 0.11. At
physiological temperature, the cholesterol gradient in ROS, which spans
from 5 to 30 mol %, corresponds to a shift in Gibbs free energy ( Cholesterol Reduces Membrane Free Volume
(fv)--
Variation in cholesterol content of disk
membranes resulted in substantial changes in the motional and
orientational properties of the hydrophobic fluorescence probe DPH as
well as the DPH fluorescence lifetime. The intensity-weighted average
fluorescence lifetime of DPH varied directly with membrane cholesterol
content and ranged from < Direct Rhodopsin-Cholesterol Interaction?--
The absorption
spectrum of the retinal chromophore in rhodopsin is determined by its
interactions with the amino acid side chains of opsin and is therefore
sensitive to protein conformational changes in the intrahelical
retinal-binding site (29, 30). Changes in any rhodopsin absorption
spectrum in disks with variation in cholesterol content would reveal
the structural perturbation in the intrahelical domain of rhodopsin
induced by cholesterol. Depletion or enrichment of cholesterol in disk
membranes had no effect on the absorption spectrum of dark-adapted
rhodopsin, which has an absorption maximum at 498 nm (Fig.
4A). The absorption spectrum
of photoactivated rhodopsin is established within tens of milliseconds
and consists of two absorbing species, MI (490 nm) and MII (388 nm),
which exist in a metastable equilibrium. The absorption peaks of both
MI and MII were unchanged by cholesterol depletion or enrichment in
disk membranes (Fig. 4B). However, relative intensities of
the MI and MII absorption bands were shifted by cholesterol
manipulation, reflecting the modulation of Keq by cholesterol. Because cholesterol enrichment or depletion induced no
shift in the absorption peak position of either dark-adapted or
light-activated rhodopsin, specific interaction between cholesterol and
rhodopsin could be ruled out.
Effect of Cholesterol on Rhodopsin Thermal Stability--
The
thermal unfolding of rhodopsin in ROS disk membranes was examined via
DSC. Overall, increased cholesterol levels in disk membranes resulted
in a higher transition temperature for the thermal denaturation of
rhodopsin. In control disk membranes that had not been exposed to MBCD
rhodopsin underwent thermal unfolding at 74.2 ± 0.05 °C, in
close agreement with previous investigations (31). Addition of
cholesterol to 38 mol % raised the thermal unfolding temperature of
rhodopsin to 74.8 °C, and depletion of cholesterol to 4 mol % lowered the thermal unfolding temperature to 73.7 °C as shown in
Fig. 5.
Membrane Cholesterol Manipulation Using MBCD--
Our results
demonstrate that disk membranes can be depleted or enriched with
cholesterol using MBCD as a cholesterol donor or acceptor. This method
has advantages of shorter preparation time, wider ranges of cholesterol
concentrations achieved in disk membranes, and more quantitative data
when compared with the previous method of manipulating the cholesterol
content of disk membranes using phospholipid vesicles (32). Cholesterol
exchange between disk membranes and MBCD was found to follow an
equilibrium-partition model with a partition coefficient of 5.2 in
favor of the disk membrane. The same model may also apply to other
cellular membranes in which MBCD is used to manipulate membrane
cholesterol. However, MBCD should be used with caution because it was
found to bind phospholipids as well, especially at concentrations of
MBCD greater than 15 mM (Table I). If significant amounts
of phospholipid are extracted from membranes by MBCD, membrane
structure may be disturbed unintentionally. Thus, effects caused
by a loss of phospholipid may inadvertently be attributed to changes in
cholesterol concentration. A general guideline for preparation of
cholesterol-depleted membranes is to use a high molar ratio of
MBCD/membrane phospholipid (up to 10:1) to maximize the transfer of
cholesterol from membranes to MBCD. For preparation of
cholesterol-enriched membranes a low ratio of MBCD/membrane
phospholipid and a high donor cholesterol concentration should be used
to maximize transfer of cholesterol from MBCD to membranes.
Cholesterol Inhibits Rhodopsin Activation--
Elevated
cholesterol levels in disk membranes correlated with lower values of
Keq for the MI-MII equilibrium, which is
consistent with studies in reconstituted rhodopsin-containing model
membranes (33). The highest Keq values were
observed in disk membranes containing the lowest amount of cholesterol
(4 mol %), which infers a physiological consequence of the cholesterol
gradient along the stack of disks in ROS (11). The basal disks contain
the highest amount of cholesterol (30 mol %), which should have lower Keq values. These disks are gradually depleted
of cholesterol as they move to the top of the stack. The apical disks
contain only 5 mol % cholesterol so that increased rhodopsin
activation is achieved. Because visual signaling is transferred from
rhodopsin to phosphodiesterase via coupling to transducin, the
cholesterol effect on rhodopsin activation would likely be propagated
along the signaling cascade. This is consistent with a study by
Boesze-Battaglia and Albert (12) in which a lower phosphodiesterase
activity was observed in disks with higher cholesterol levels.
Mechanism of Receptor Inhibition by Cholesterol--
Cholesterol
alters the function of a variety of receptors and channels (1-5). The
current mechanistic views on cholesterol-induced effects on membrane
protein function fall into the following two categories: 1) modulation
by specific cholesterol-protein interaction and 2) modulation via
cholesterol-induced changes in phospholipid acyl chain packing. To date
most studies have focused on changes in protein function upon
cholesterol removal and/or enrichment (1-6). Perturbations of protein
structure or membrane physical properties by cholesterol have been
largely unexamined in native membranes under physiological conditions.
A remaining challenge for those systems reported to involve specific
interactions with cholesterol is to characterize the nature of such
interaction sites.
In this study the variation in acyl chain packing in native disk
membranes induced by cholesterol was examined using the time-resolved decay of fluorescence anisotropy of DPH. Cholesterol depletion or
enrichment resulted in substantial changes in the motional and
orientational properties of DPH, suggesting large structural perturbations in disk membrane phospholipids by cholesterol. Membrane fv was reduced by cholesterol enrichment, which
is consistent with previous studies in model membranes,
demonstrating that cholesterol induces increased order in
phospholipid acyl chain packing (20, 34).
The retinal chromophore of rhodopsin acts as an excellent reporter of
several important conformation changes that occur during formation of
the active MII state that binds transducin, the visual G protein.
During the activation process, rhodopsin proceeds through a series of
photointermediates with distinct conformations, and changes in
chromophore conformation and protein-induced electrostatic environment
result in distinct absorption spectra for each intermediate (29, 30).
In this study the effects of membrane cholesterol on the absorption
spectra of three important conformational states of rhodopsin were
examined. Dark-adapted rhodopsin is equivalent to an antagonist-bound
state, whereas MI is an agonist-bound inactive conformation, and MII is
the agonist-bound active conformation that participates in visual
signal transduction. The absorption spectra of these three
conformational states was unaffected by cholesterol over the entire
range of membrane cholesterol concentrations examined as shown in Fig.
4. The lack of variation in the absorption maxima of agonist- or
antagonist-bound rhodopsin indicates that no protein conformational
changes in the intrahelical retinal-binding domain are induced by
cholesterol. Accordingly, specific cholesterol-rhodopsin interactions
are unlikely to be involved in the inhibition of rhodopsin conformation
changes by cholesterol.
Another line of evidence relative to rhodopsin-cholesterol interactions
comes from studies of the effects of membrane cholesterol on acyl chain
packing free volume as quantified by fv and
formation of the active MII conformation as quantified by
Keq. These quantities are linearly related over
the entire range of cholesterol concentrations examined, which was from
4 to 38 mol % (Fig. 6). A linear
correlation between Keq and
fv with changes in bilayer cholesterol was
observed previously in studies of rhodopsin reconstituted in
phospholipid membranes (33). It is significant that the correlation
shown in Fig. 6 was obtained for measurements at 37 °C,
demonstrating that at physiological temperature cholesterol-induced
changes in acyl chain packing and rhodopsin activation are tightly
coupled. A reduction of membrane free volume would impose an
energy barrier to the MI to MII transition, which is accompanied by a
100 ml/mole volume expansion (35, 36), that would reduce the
equilibrium concentration of MII, the active conformation of
photoexcited rhodopsin. The effect of reduced free volume in the disk
membrane with cholesterol enrichment on rhodopsin conformational
flexibility is also demonstrated by the higher thermal stability of
rhodopsin in the presence of more ordered acyl chain packing as shown
in Fig. 5 and previously by Albert et al. (32). Given that
cholesterol had no observable structural perturbation on rhodopsin and
that Keq and fv are
linearly correlated over the entire range of membrane cholesterol
concentration, we conclude that cholesterol inhibits rhodopsin
activation via an indirect effect of cholesterol on phospholipid acyl
chain packing (i.e. by a free volume-mediated mechanism).
A recent study reports that rod outer segment membranes contain
detergent-resistant membranes or lipid rafts (37). This term is
generally applied to microdomains enriched in cholesterol and
sphingomyelin, which are insoluble in mild Triton X-100 at 4 °C (38,
39). The observation relative to ROS disk membranes is unusual in that
these membranes contain insignificant amounts of sphingomyelin (13,
14). The results presented in the current study demonstrate that disk
membrane cholesterol concentration is inversely correlated with
rhodopsin activation as measured by the extent of MII formation.
Reducing disk cholesterol from 15 to 4 mol %, which should disrupt or
reduce lipid raft formation, actually resulted in higher levels of
rhodopsin activation. These results are consistent with recent reports
for rhodopsin reconstituted in bilayers formed from phosphatidylcholine
and varying levels of cholesterol (26). In these reconstituted systems
it is observed that the level (26) and rate (40) of coupling of MII to
G protein was inversely correlated with the cholesterol concentration. In the current study a linear correlation was observed between Keq for the MI-MII equilibrium and
fv from 4 to 38 mol % cholesterol at
physiological temperature. Here again the results mimic those observed
with single component phosphatidylcholine systems with and without
cholesterol (8, 33) in which no lipid rafts existed. If increasing
cholesterol concentration is accompanied by lateral domain or raft
formation in the disk membrane, then this should be manifested as a
discontinuity in the cholesterol dependence of the activation of
rhodopsin. However, we observed a tight linear correlation of rhodopsin
activation with fv, which is a measure of the
bulk or average phospholipid acyl chain packing in the membrane.
Therefore, the results of the present study do not show the anticipated
evidence for cholesterol-dependent formation of lipid rafts
at cholesterol levels well below and above those of the native disk membrane.
Disk phospholipid acyl chains are ~50% DHA, and ~25% of the disk
phospholipids contain DHA in both the sn-1 and
sn-2 positions (13). In model membranes formed from
di22:6PC, di16:0PC, and cholesterol rhodopsin preferentially partitions
into a di22:6PC-rich domain, whereas cholesterol partitions primarily
into a domain rich in the saturated phospholipid (31). This observation
demonstrates that rhodopsin prefers a liquid-disordered rather than a
liquid-ordered phase. Therefore, if lipid rafts exist in disk membranes
at physiological conditions and are in the liquid-ordered phase as was
reported in other systems then rhodopsin will likely be excluded from
these domains. In addition, the evidence from reconstituted systems (26, 40) demonstrates that the presence of cholesterol-induced acyl
chain ordering (such as that reported for lipid rafts) would reduce the
rate and level of rhodopsin-transducin coupling, thereby diminishing
the efficiency of signal transduction. Given the preference of
cholesterol for saturated versus polyunsaturated acyl chains and the presence of dipolyunsaturated phospholipids in the disk membrane, there is the potential to form cholesterol-enriched and
cholesterol-depleted lateral domains in the disk membrane (31).
However, given the overall level of polyunsaturated acyl chains in the
disk membrane, these domains will likely have very different properties
from those found in high sphingomyelin-containing membranes, which
might result in a more homogeneous distribution of rhodopsin.
Cholesterol has been found to reduce membrane free volume by ordering
phospholipid acyl chain packing. Integral membrane receptors and
channels are imbedded in a lipid matrix and need to undergo conformational changes during activation. A simple two-state model described as an inactive state (I) and an activated state (A) illustrates the potential effect of cholesterol on membrane protein function. If the transition from I to A involves a net volume expansion
such as the MI to MII transition of photoactivated rhodopsin, a more
ordered phospholipid acyl chain packing imposed by cholesterol would
inhibit such a transition. Inhibition of membrane protein function
would be expected by cholesterol enrichment as is observed in this
study. On the other hand, if the transition from I to A involves a net
volume reduction, membrane ordering by cholesterol would facilitate
such a transition and in turn enhance membrane protein function. The
parallel behavior for the cholesterol dependence of rhodopsin
activation in the native disk membranes and reconstituted bilayer
systems suggests a mechanism of action of cholesterol that involves its
effect on phospholipid acyl chain packing. If cholesterol-induced
domain formation does occur in disks then their presence may be
manifested in the coupling of the protein constituents in the signaling
pathway rather than in a direct effect on the conformational changes
associated with the activation of rhodopsin. The discussion of the
effect of cholesterol on rhodopsin may extend to other membrane
proteins as well, including receptors and channels, which undergo a
functional conformational change in a region within the membrane lipid.
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Published, JBC Papers in Press, March 11, 2002, DOI 10.1074/jbc.M200594200
The abbreviations used are:
ROS, rod outer
segment;
DHA, docosahexanoic acid;
DPH, 1,6-diphenyl-1,3,5-hexatriene;
DSC, differential scanning calorimetry;
fv, phospholipid acyl chain packing free volume;
MBCD, methyl-
Manipulation of Cholesterol Levels in Rod Disk Membranes by
Methyl-
-cyclodextrin
EFFECTS ON RECEPTOR ACTIVATION*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-cyclodextrin as a cholesterol donor or
acceptor. Cholesterol exchange followed a simple equilibrium
partitioning model with a partition coefficient of 5.2 ± 0.8 in
favor of the disk membrane. Reduced cholesterol in disk membranes
resulted in a higher proportion of photolyzed rhodopsin being converted
to the G protein-activating metarhodopsin II (MII) conformation,
whereas enrichment of cholesterol reduced the extent of MII formation.
Time-resolved fluorescence anisotropy measurements using
1,6-diphenyl-1,3,5-hexatriene showed that increasing cholesterol
reduced membrane acyl chain packing free volume as characterized by the
parameter fv. The level of MII formed showed a
positive linear correlation with fv over the
range of 4 to 38 mol % cholesterol. In addition, the thermal stability
of rhodopsin increased with mol % of cholesterol in disk membranes. No
evidence was observed for the direct interaction of cholesterol with
rhodopsin in either its agonist- or antagonist-bound form. These
results indicate that cholesterol mediates the function of the G
protein-coupled receptor, rhodopsin, by influencing membrane lipid
properties, i.e. reducing acyl chain packing free volume,
rather than interacting specifically with rhodopsin.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-cyclodextrin (MBCD) as a cholesterol donor or
acceptor. The influence of cholesterol on rhodopsin activation was
characterized by examining the conformational equilibrium between MI
and MII. The effect of cholesterol on membrane acyl chain packing was
characterized using the time-resolved decay of the fluorescence
anisotropy of DPH (19, 20). Examining the cholesterol dependence of the
absorption spectrum of the dark-adapted and light-activated states of
rhodopsin allowed an assessment of any cholesterol-induced structural
perturbation in the intrahelical binding pocket of the retinal
chromophore. Perturbation of the overall structural stability of
rhodopsin by cholesterol was assessed using DSC to measure the thermal
denaturation of rhodopsin. Our results demonstrate that cholesterol
inhibits rhodopsin activation by reducing the equilibrium concentration
of MII in the absence of direct interaction with rhodopsin; however,
this effect is linked directly to cholesterol-induced reductions in
membrane acyl chain packing free volume. These results indicate that
cholesterol modulates rhodopsin activation by influencing membrane
phospholipid acyl chain packing rather than via direct interaction with rhodopsin.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
> was calculated. Measured
polarization-dependent differential phases and modulation ratios for each sample were combined with the measured total intensity decay to yield the anisotropy decay, r(t). An empirical
description of all anisotropy decays was obtained via analysis in terms
of a simple sum of exponentials of the form shown in Equation 1,
(Eq. 1)
is the non-decaying
anisotropy remaining at the longest time measured in the experiment,
1 is the rotational correlation time, and
1 is the functional contribution of each exponential term.
v,
which is directly proportional to the extent to which DPH is randomly
oriented in the membrane (19, 27). All analyses of differential
polarization data were performed with NONLIN (10, 28), and subroutines
specifying the fitting function were written by the authors.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (15K):
[in a new window]
Fig. 1.
Manipulation of disk cholesterol levels.
A, disk cholesterol depletion by MBCD. Cholesterol in
MBCD-treated disks, normalized to that in control disks without MBCD
treatment, is plotted against the molar ratio of MBCD to total
phospholipids, [MBCD]/[Pi], in the disk membranes. Data
shown are from two sets of experiments with 1.0 mM (
)
and 1.6 mM (
) disk membrane phospholipids. The
solid curve was fitted according to equilibrium partitioning
of cholesterol between MBCD and disk membranes. B,
cholesterol enrichment in 1.0 mM disk membrane
phospholipids by cholesterol-MBCD complex.
, experimentally
determined cholesterol concentration in disk membranes;
, calculated
cholesterol concentration in disk membranes according to the
equilibrium partition model using a partition coefficient derived from
the data in A.
Amount of phospholipids extracted from disk membranes by MBCD
G)
associated with MI-MII equilibrium toward a more positive value by 189 cal/mol, resulting in the formation of approximately 17% less MII.

View larger version (13K):
[in a new window]
Fig. 2.
Effect of cholesterol on the MI-MII
equilibrium constant (Keq). Equilibrium spectra were
acquired in disk membranes containing 4, 12, 15, and 38 mol % cholesterol in pH 7.5 TBS buffer at 37 °C. Sample containing 15 mol
% cholesterol was the control disks without MBCD treatment, whereas
other samples were prepared using MBCD as cholesterol donor or
acceptor. Keq was calculated from deconvolved
MI-MII equilibrium spectra as described under "Experimental
Procedures."
> of 7.7 ± 0.1 ns for 4 mol % cholesterol to <
> of 9.8 ± 0.1 ns for 38 mol % cholesterol
at 37 °C (Fig. 3A). The
magnitude of the increase in DPH fluorescence lifetime with increased
cholesterol is very similar to what is observed in pure lipid bilayers
(20), and it reflects cholesterol-induced reduction in water
penetration. Alteration in the rate of DPH motion with changes in
membrane cholesterol content is indicated by changes in
D
, the diffusion constant for DPH rotation about its
long axis (obtained from the Brownian rotational diffusion model).
Depletion of cholesterol increased D
, indicating more
rapid rotational motion of DPH, whereas cholesterol enrichment reduced
D
as shown in Fig. 3B. A series of studies
demonstrate that the overall orientational order of DPH in a
phospholipid bilayer is well summarized by the parameter
fv, a measure of phospholipid acyl chain packing
free volume (19, 20). The untreated disk membranes had a cholesterol content of 15 mol %. At 37 °C upon reduction of membrane
cholesterol to 4 mol %, fv increased by 45%,
whereas enrichment of cholesterol to 38 mol % reduced
fv by 30% as shown in Fig. 3C.
Intermediate cholesterol contents had varied fv
values within this range. Previous studies show that this reduction in
fv corresponds to a significant decrease in acyl
chain packing free volume comparable with the change in acyl chain
packing induced by a reduction in temperature of 10 °C.

View larger version (26K):
[in a new window]
Fig. 3.
Summary of the effects of cholesterol
concentration in the disk membrane on DPH fluorescent lifetime and
anisotropy decay. A, intensity-weighted average
fluorescence lifetime, <
>. B, the diffusion coefficient
for DPH rotation about its long axis. C, phospholipid acyl
chain packing free volume parameter, fv. This
parameter is calculated from the DPH orientational distribution
function that results from analysis of anisotropy decay data in terms
of the Brownian rotational diffusion model (20). Samples contained the
same cholesterol levels as described in the legend to Fig. 2.
Open bars at 15 mol % cholesterol represent the control
disk sample, which received no MBCD treatment.

View larger version (20K):
[in a new window]
Fig. 4.
Effect of cholesterol on rhodopsin absorption
spectrum. UV-visible absorption spectra of dark-adapted rhodopsin
(A) and light-activated rhodopsin (B) from
cholesterol-depleted disks containing 5 mol % cholesterol (solid
curves), control disks containing 15 mol % cholesterol
(dotted curves), and cholesterol-enriched disks containing
47 mol % cholesterol (dashed curves). All spectra were
acquired in TBS, pH 7.5, at 20 °C. Absorption peaks for
dark-adapted rhodopsin, MI, and MII are marked with dashed
lines for comparison.

View larger version (15K):
[in a new window]
Fig. 5.
Effect of membrane cholesterol concentration
on the thermal denaturation of rhodopsin. Samples contained 1.0 mg/ml rhodopsin in pH 7.0 PIBS buffer and were scanned at
0.5 °C/min.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (13K):
[in a new window]
Fig. 6.
Correlation of the MI-MII equilibrium
constant, Keq, and the phospholipid acyl chain packing free
volume parameter, fv,
from samples varying in cholesterol concentration as described in the
legend to Fig. 2 at 37 °C. The open
circle is the control disk at 15 mol % cholesterol, which
received no MBCD treatment.
![]()
FOOTNOTES
To whom correspondence should be addressed: 12420 Parklawn Dr.,
Rm. 158, Rockville, MD 20852. Tel.: 301-594-3608; Fax: 301-594-0035; E-mail: litman@helix.nih.gov.
![]()
ABBREVIATIONS
-cyclodextrin;
MI, metarhodopsin I;
MII, metarhodopsin II;
Keq, MI-MII equilibrium constant;
PC, phosphatidylcholine;
TBS, Tris-buffered saline;
PIPES, 1,4-piperazinediethanesulfonic acid.
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Nunez, M. T.,
and Glass, J.
(1982)
Biochemistry
21,
4139-4143[CrossRef][Medline]
[Order article via Infotrieve]
2.
Fernandez-Ballester, G.,
Castresana, J.,
Fernandez, A. M.,
Arrondo, J. L.,
Ferragut, J. A.,
and Gonzales-Ros, J. M.
(1994)
Biochemistry
33,
4065-4071[CrossRef][Medline]
[Order article via Infotrieve]
3.
Gimpl, G.,
Burger, K.,
and Fahrenholz, F.
(1997)
Biochemistry
36,
10959-10974[CrossRef][Medline]
[Order article via Infotrieve]
4.
Sooksawate, T.,
and Simmonds, M. A.
(2001)
Neuropharmacology
40,
178-184[CrossRef][Medline]
[Order article via Infotrieve]
5.
Pang, L.,
Graziano, M.,
and Wang, S.
(1999)
Biochemistry
38,
12003-12011[CrossRef][Medline]
[Order article via Infotrieve]
6.
Bastiaanse, E. M.,
Hold, K. M.,
and Van der Larse, A.
(1997)
Cardiovasc. Res.
33,
272-283 7.
Mitchell, D. C.,
Straume, M.,
and Litman, B. J.
(1992)
Biochemistry
31,
662-670[CrossRef][Medline]
[Order article via Infotrieve]
8.
Litman, B. J.,
and Mitchell, D. C.
(1996)
Lipids
31 (suppl.),
S193-S197
9.
Litman, B. J.,
and Mitchell, D. C.
(1996)
in
Biomembranes
(Lee, A., ed)
, pp. 1-32, JAI Press, Greenwich, CT
10.
Straume, M.,
Mitchell, D. C.,
Miller, J. L.,
and Litman, B. J.
(1990)
Biochemistry
29,
9135-9142[CrossRef][Medline]
[Order article via Infotrieve]
11.
Boesze-Battaglia, K.,
Hennessey, T.,
and Albert, A. D.
(1989)
J. Biol. Chem.
264,
8151-8155 12.
Boesze-Battaglia, K.,
and Albert, A. D.
(1990)
J. Biol. Chem.
265,
20727-20730 13.
Stinson, A. M.,
Wiegand, R. D.,
and Anderson, R. E.
(1991)
Exp. Eye Res.
52,
213-218[CrossRef][Medline]
[Order article via Infotrieve]
14.
Yuan, C.,
Chen, H.,
Anderson, R. E.,
Kuwata, O.,
and Ebrey, T. G.
(1998)
Comp. Biochem. Physiol. B Biochem. Mol. Biol.
120,
785-789[CrossRef][Medline]
[Order article via Infotrieve]
15.
Smith, H. G. J.,
and Litman, B. J.
(1982)
Methods Enzymol.
81,
57-61[Medline]
[Order article via Infotrieve]
16.
Papermaster, D. S.,
and Dreyer, W. J.
(1974)
Biochemistry
13,
2438-2444[CrossRef][Medline]
[Order article via Infotrieve]
17.
Palczewski, K.,
Kumasaka, T.,
Hori, T.,
Behnke, C. A.,
Motoshima, H.,
Fox, B. A.,
Trong, I. L.,
Teller, D. C.,
Okada, T.,
Stenkamp, R. E.,
Yamamoto, M.,
and Miyano, M.
(2000)
Science
289,
739-745 18.
Hargrave, P. A.
(2001)
Investig. Ophthalmol. Vis. Sci.
42,
3-9 19.
Straume, M.,
and Litman, B. J.
(1987)
Biochemistry
26,
5113-5120[CrossRef][Medline]
[Order article via Infotrieve]
20.
Mitchell, D. C.,
and Litman, B. J.
(1998)
Biophys. J.
75,
896-908 21.
Allain, C. C.,
Poon, L. S.,
Chan, C. S.,
Richmond, W.,
and Fu, P. C.
(1974)
Clin. Chem.
20,
470-475[Abstract]
22.
Miller, J. L.,
Fox, D. A.,
and Litman, B. J.
(1986)
Biochemistry
25,
4983-4988[CrossRef][Medline]
[Order article via Infotrieve]
23.
Bartlett, G. R.
(1959)
J. Biol. Chem.
234,
587-596
24.
Jackson, M. L.,
and Litman, B. J.
(1985)
Biochim. Biophys. Acta
812,
369-376[Medline]
[Order article via Infotrieve]
25.
Lowry, O. H.,
Rosebrough, N. J.,
Farr, A. L.,
and Randall, R. J.
(1951)
J. Biol. Chem.
193,
265-272 26.
Niu, S. L.,
Mitchell, D. C.,
and Litman, B. J.
(2001)
J. Biol. Chem.
276,
42807-42811 27.
Mitchell, D. C.,
and Litman, B. J.
(1998)
Biophys. J.
74,
879-891 28.
Johnson, M. L.,
and Faunt, L. M.
(1992)
Methods Enzymol.
210:1-37,
1-37[CrossRef][Medline]
[Order article via Infotrieve]
29.
Lewis, J. W.,
and Kliger, D. S.
(1992)
J. Bioenerg. Biomembr.
24,
201-210[CrossRef][Medline]
[Order article via Infotrieve]
30.
Yoshizawa, T.,
Shichida, Y.,
and Matuoka, S.
(1984)
Vision Res.
24,
1455-1463[CrossRef][Medline]
[Order article via Infotrieve]
31.
Polozova, A.,
and Litman, B. J.
(2000)
Biophys. J.
79,
2632-2643 32.
Albert, A. D.,
Boesze-Battaglia, K.,
Paw, Z.,
Watts, A.,
and Epand, R. M.
(1996)
Biochim. Biophys. Acta
1297,
77-82[CrossRef][Medline]
[Order article via Infotrieve]
33.
Mitchell, D. C.,
Straume, M.,
Miller, J. L.,
and Litman, B. J.
(1990)
Biochemistry
29,
9143-9149[CrossRef][Medline]
[Order article via Infotrieve]
34.
Straume, M.,
and Litman, B. J.
(1987)
Biochemistry
26,
5121-5126[CrossRef][Medline]
[Order article via Infotrieve]
35.
Attwood, P. V.,
and Gutfreund, H.
(1980)
FEBS Lett.
119,
323-326[CrossRef][Medline]
[Order article via Infotrieve]
36.
Lamola, A. A.,
Yamane, T.,
and Zipp, A.
(1974)
Biochemistry
13,
738-745[CrossRef][Medline]
[Order article via Infotrieve]
37.
Seno, K.,
Kishimoto, M.,
Abe, M.,
Higuchi, Y.,
Mieda, M.,
Owada, Y.,
Yoshiyama, W.,
Liu, H.,
and Hayashi, F.
(2001)
J. Biol. Chem.
276,
20813-20816 38.
London, E.,
and Brown, D. A.
(2000)
Biochim. Biophys. Acta
1508,
182-195[Medline]
[Order article via Infotrieve]
39.
Simons, K.,
and Ikonen, E.
(1997)
Nature
387,
569-572[CrossRef][Medline]
[Order article via Infotrieve]
40.
Mitchell, D. C.,
Niu, S. L.,
and Litman, B. J.
(2001)
J. Biol. Chem.
276,
42801-42806
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
Q. Wang, X. Zhang, L. Zhang, F. He, G. Zhang, M. Jamrich, and T. G. Wensel Activation-dependent Hindrance of Photoreceptor G Protein Diffusion by Lipid Microdomains J. Biol. Chem., October 31, 2008; 283(44): 30015 - 30024. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Bennett and D. C. Mitchell Regulation of Membrane Proteins by Dietary Lipids: Effects of Cholesterol and Docosahexaenoic Acid Acyl Chain-Containing Phospholipids on Rhodopsin Stability and Function Biophys. J., August 1, 2008; 95(3): 1206 - 1216. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Boesze-Battaglia, M. Damek-Poprawa, D. C. Mitchell, L. Greeley, R. S. Brush, R. E. Anderson, M. J. Richards, and S. J. Fliesler Alteration of retinal rod outer segment membrane fluidity in a rat model of Smith-Lemli-Opitz syndrome J. Lipid Res., July 1, 2008; 49(7): 1488 - 1499. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lakkaraju, S. C. Finnemann, and E. Rodriguez-Boulan The lipofuscin fluorophore A2E perturbs cholesterol metabolism in retinal pigment epithelial cells PNAS, June 26, 2007; 104(26): 11026 - 11031. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Soubias, W. E. Teague, and K. Gawrisch Evidence for Specificity in Lipid-Rhodopsin Interactions J. Biol. Chem., November 3, 2006; 281(44): 33233 - 33241. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Powers, K. Szaszi, R. G. Khadaroo, P. S. Tawadros, J. C. Marshall, A. Kapus, and O. D. Rotstein Oxidative stress generated by hemorrhagic shock recruits Toll-like receptor 4 to the plasma membrane in macrophages J. Exp. Med., August 7, 2006; 203(8): 1951 - 1961. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tsamaloukas, H. Szadkowska, and H. Heerklotz Thermodynamic Comparison of the Interactions of Cholesterol with Unsaturated Phospholipid and Sphingomyelins Biophys. J., June 15, 2006; 90(12): 4479 - 4487. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J Johnson and E. J Schaefer Potential role of dietary n-3 fatty acids in the prevention of dementia and macular degeneration Am. J. Clinical Nutrition, June 1, 2006; 83(6): S1494 - 1498S. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Xu, S.-I. Yoon, P. Huang, Y. Wang, C. Chen, P. L.-G. Chong, and L.-Y. Liu-Chen Localization of the {kappa} Opioid Receptor in Lipid Rafts J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1295 - 1306. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Grossfield, S. E. Feller, and M. C. Pitman A role for direct interactions in the modulation of rhodopsin by {omega}-3 polyunsaturated lipids PNAS, March 28, 2006; 103(13): 4888 - 4893. [Abstract] [Full Text] [PDF] |
||||
![]() |